Company Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally.
It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns.
The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors.
ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
On October 26, 2023, the voluntary petition of ViewRay , Inc. for reorganization under Chapter 11 was converted to Chapter 7.
It had filed for Chapter 11 bankruptcy on July 16, 2023.
| Country | United States |
| Founded | 2004 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 295 |
Contact Details
Address: 2 Thermo Fisher Way Oakwood Village, Ohio 44146 United States | |
| Phone | 440-703-3210 |
Stock Details
| Ticker Symbol | VRAYQ |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001597313 |
| Employer ID | 42-1777485 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Paul Ziegler Jr., J.D. | President, Chief Executive Officer and Director |
| Dr. James F. Dempsey Ph.D. | Founder and Chief Scientific Officer |
| Jacob Edward Signoriello | Interim Chief Financial Officer |
| Drew Hill | Senior Vice President of Operations and Development |
| Matt Harrison | Director of Investor Relations |
| Sanket Shah J.D. | Senior Vice President and General Counsel |
| Karen Hackstaff | Vice President of Marketing |
| Julianne Mast | Vice President of Human Resources |
| Dr. Martin Fuss M.D., Ph.D. | Chief Medical Officer |
| Adam Podbelski | Senior Vice President of Commercial Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Sep 8, 2023 | 25-NSE | Filing |
| Sep 7, 2023 | 8-K | Current Report |
| Aug 14, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Aug 8, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Aug 3, 2023 | 8-K | Current Report |
| Jul 25, 2023 | 144 | Filing |
| Jul 25, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |